-
1
Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
Published 2024-05-01Subjects: Get full text
Article -
2
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
Published 2025-01-01Subjects: “…androgen receptor signalling inhibitor (ARSI)…”
Get full text
Article